Overview

Whilst every parent eagerly anticipates the moment their newborn takes their first breath, that pivotal moment is a struggle for some premature infants, as each breath is turned into a challenge. This is due to the presence of a condition called Neonatal Respiratory Distress Syndrome (NRDS).

This article delves into NRDS and explores its origins, challenges and the journey to overcoming this critical condition. With advancements in science and medicine, the narrative surrounding NRDS is hopeful, and with the right medical interventions and appropriate care, your newborn will likely recover fully. 

What is Neonatal Respiratory Distress Syndrome (NRDS)?

Neonatal Respiratory Distress Syndrome (NRDS) arises when the baby’s lungs are not fully developed, thus, affecting their ability to breathe effectively when they are born. This syndrome is a significant issue in neonatal care, often requiring admission to the neonatal intensive care units (NICU) and contributing to neonatal morbidity rates. Therefore it is crucial to deepen our understanding of NRDS and ensure that it can be diagnosed quickly and successfully treated.¹

NRDS typically affects premature babies, presenting at a higher risk and greater severity to smaller and more premature neonates. NRDS occurs when the baby’s lungs do not produce enough surfactant. Surfactant is an important substance produced by the lungs that helps keep the air sacs open and aid in gas exchange. 

Without adequate surfactant, the lungs cannot stay inflated leading to collapse and subsequent breathing difficulties.² This compromised respiratory function reduces the passage of oxygen into the lungs and bloodstream, which can be detrimental and potentially cause severe health complications if not treated.

Whilst the biggest risk factor for NRDS is premature birth, other factors may also contribute to its development, such as poorly controlled maternal diabetes, caesarean section delivery and low birth weight.¹

Symptoms and diagnosis of NRDS

NRDS can have detrimental consequences on the newborn, however, if there is early recognition of symptoms, and management begins promptly, outcomes can be much more promising. 

Characteristic symptoms of NRDS, alongside difficulty breathing, include blue-tinged lips, blue fingers and toes, fast and shallow breathing, chest retractions (where the chest pulls in with each breath due to low air pressure in the lungs), flaring nostrils and grunting sounds when breathing.³ 

Upon observing these symptoms of breathing difficulties, a combination of tests may be carried out to rule out other causes and give a diagnosis of NRDS. This includes observing clinical signs through physical examination, carrying out blood tests to check for infection, measuring the amount of oxygen in the neonate’s blood and carrying out a chest X-ray to check if the lungs look distinctively cloudy.⁴ 

If the symptoms of NRDS fail to be recognised and the cause of breathing difficulties is not treated, complications can develop such as respiratory failure and even death, therefore early interventions must be made.¹

Treatment and management of NRDS

Immediate interventions are crucial upon the diagnosis of NRDS to ensure adequate breathing and circulation are restored, and they are often initiated in the delivery room before your baby is transferred to the neonatal unit. 

Oxygen therapy is central to managing NRDS and can be delivered through various methods depending on the infant's needs. Some common methods include a mask worn over the nose/face, placement in an incubator or through tubes placed into the nose which aims to restore oxygen levels in the blood.⁵ 

A pulse oximeter will remain attached to your baby whilst monitoring oxygen levels in the baby’s blood, This is paramount for continuous assessment of their oxygen saturation and determine the amount of oxygen therapy required. Suppose oxygen levels drop below the desired range, oxygen therapy will be delivered via a breathing machine called a ventilator, which can take over breathing for your baby to restore the amount of oxygen in their blood. 

In addition to oxygen therapy, surfactant replacement therapy may also be necessary, which involves delivering an artificial surfactant to the infant through a breathing tube to replace the surfactant that the baby’s lungs have failed to produce. Supportive care is also an integral part of the treatment of NRDS. Supportive care includes measures such as temperature regulation to prevent hypothermia which can further aggravate the effects that low oxygen can have.

Furthermore, fluids and nutrition will also be given through a tube connected to a vein to maintain their recovery through adequate hydration and nourishment, and antibiotics may be given to prevent infection.⁶ Infants with NRDS may also receive long-term care and follow-up monitoring to address complications and support their development. This may encompass rehabilitation services, developmental support and multidisciplinary interventions to optimise outcomes and quality of life.

Prevention of NRDS

Whilst NRDS can be treated successfully with the appropriate interventions, it is also important to focus on how it can be prevented. For women at risk of early delivery, identification is made through prenatal screening. Steroid medications can be administered to the mother to prevent respiratory distress by helping the baby’s lungs mature.

The steroids can accelerate surfactant production in the foetal lungs before birth, reducing the likelihood of NRDS.⁷ Furthermore, ensuring underlying conditions such as diabetes are maintained through prenatal to optimise maternal health can prevent the development of NRDS.

Complications of NRDS

Whilst most babies are successfully treated, some complications could develop. Babies with NRDS may develop pneumothorax (leakage of air into the chest cavity between the lung and chest wall, leading to lung collapse), internal bleeding or bronchopulmonary dysplasia (a chronic lung condition due to lung inflammation and scarring). The risk of developing these complications may be increased if your newborn requires mechanical ventilation to restore significantly depleted blood oxygen levels.^8,9

If the baby’s brain is damaged during NRDS they may have a higher risk of further problems later on in life including developmental disabilities such as learning difficulties, movement problems, impaired hearing and impaired vision.

Advances in research and treatment

T Artificialsurfactant has been a pivotal step in NRDS treatment. Furthermore, new treatment developments show promise and have continuously improved over the years, one being the use of steroids to promote the development of the lungs and reduce the likelihood of NRDS.

However, the rate of research into new treatment options is not able to keep up with the ever-growing incidence of premature birth, which is by far the biggest risk factor. Therefore, research into strategies to prevent premature births is crucial to preventing babies from developing NRDS.⁸

FAQ's

What is Neonatal Respiratory Distress Syndrome (NRDS)?

NRDS happens when a baby’s lungs have not developed correctly, causing breathing difficulties at birth.

What causes NRDS in newborns?

It occurs when the lungs do not produce enough surfactant, a substance which prevents the lungs from collapsing. In NRDS the lack of surfactant prevents the lungs from inflating.

What are the symptoms of NRDS?

Typical symptoms of breathing difficulty include blue-tinged lips, blue fingers and toes, fast and shallow breathing, flaring nostrils, chest retractions and a grunting sound when breathing

How is NRDS diagnosed?

A combination of physical examinations, blood tests to rule out other causes such as infection, pulse oximetry test to measure the amount of oxygen in the blood and a chest X-ray to check for the characteristic cloudy appearance of the lungs.

What are the risk factors for NRDS?

The main risk factor is premature birth because the lungs have not been able to develop properly at early delivery. However maternal diabetes, low birth weight and birth by cesarean section can also increase the chance of an infant developing NRDS.

How is NRDS treated?

Oxygen therapy in the form of an incubator or ventilator and surfactant therapy if needed. Also, supportive care such as temperature regulation, intravenous fluid, nutrition and antibiotics.

What are the potential complications of NRDS?

Pneumothorax, internal bleeding, bronchopulmonary dysplasia and developmental problems such as vision, hearing, movement and learning disabilities.

What are future advancements that could be made in NRDS management?

Whilst many different advancements have been made, the biggest risk factor for NRDS of premature birth remains a big challenge. Therefore, there is currently research ongoing to look at how we can prevent preterm birth, to reduce the amount of infants developing NRDS. 

Summary

Receiving a diagnosis of NRDS for your newborn can understandably be a daunting prospect. This condition, which particularly affects premature infants, arises from a deficiency of surfactants, which hampers the ability of the lungs to inflate, making every breath a challenge. However, early recognition of symptoms such as blue-tinged lips, blue fingers and toes, rapid shallow breathing, flaring nostrils, grunting sounds when breathing and chest retractions allow for prompt medical intervention. 

Upon diagnosis of NRDS, immediate treatment involves oxygen therapy and potentially surfactant therapy, and whilst there can be complications, most babies with NRDS respond well to these interventions. Looking ahead, the focus for combating NRDS lies in reducing the occurrence of premature births, and preventing the risk of infants developing NRDS at all.